Now that their role in vaccine research is over, 117 chimpanzees in Japan
face an uncertain fate. The chimps were imported in 1975 for a hepatitis B
vaccine programme and are now in a holding facility run by the drug company
Sanwa Kagaku. The company says it can no longer afford the annual £1.5
million upkeep. There are only a few comparable chimp facilities in the world,
and all are government-subsidised. But the Japanese government is reluctant to
take responsibility for the chimps.
To continue reading, today with our introductory offers
Advertisement
More from Â鶹´«Ã½
Explore the latest news, articles and features
Popular articles
Trending Â鶹´«Ã½ articles
1
Neanderthal infants were enormous compared with modern humans
2
We might finally know how to use quantum computers to boost AI
3
Hospital-acquired pneumonia reduced by daily toothbrushing
4
The biggest threat to Chernobyl is no longer radiation
5
Are Neanderthals descendants of modern humans?
6
Parrot uses his broken beak to become a dominant male
7
CAR T-cell therapy takes woman from bedridden to 'perfectly fine'
8
How autoimmune conditions can unexpectedly drive mental illness
9
The man who crawls into the perilous heart of the Chernobyl reactor
10
Werner Herzog searches for ghost elephants in stunning new documentary
